Evidence map›Paper›PMID 29743901›Full record

ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2018

Effect of nicorandil administration on myocardial microcirculation during primary percutaneous coronary intervention in patients with acute myocardial infarction.

Chunguang Feng, Bing Han, Yi Liu, Lulu Wang, Dongdong Niu, Ming Lou, Cunzhi Lu

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04632121 (Early Administration of Oral Nicorandil in ST Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04632121 unknown statusnot on this mapstarted 2021, after this paper: background citation

Early Administration of Oral Nicorandil in ST Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial

Typeobservational_patient_registrySponsorAhmed Abdel Nasser Abdel RadyRan2021 to 2023Enrolled300ConditionsNicorandilArmsNicorandil 20 MG
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Chunguang FengInstitute of Cardiovascular Disease, Xuzhou Central Hospital, Xuzhou, China.
Bing HanInstitute of Cardiovascular Disease, Xuzhou Central Hospital, Xuzhou, China.
Yi LiuInstitute of Cardiovascular Disease, Xuzhou Central Hospital, Xuzhou, China.
Lulu WangInstitute of Cardiovascular Disease, Xuzhou Central Hospital, Xuzhou, China.
Dongdong NiuInstitute of Cardiovascular Disease, Xuzhou Central Hospital, Xuzhou, China.
Ming LouInstitute of Cardiovascular Disease, Xuzhou Central Hospital, Xuzhou, China.
Cunzhi LuInstitute of Cardiovascular Disease, Xuzhou Central Hospital, Xuzhou, China.
Xuzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrevention of the no-reflow phenomenon has a crucial role in primary percutaneous coronary intervention (P-PCI) procedures.

aimTo assess the effects of early intracoronary administration of nicorandil (NIC) during P-PCI on myocardial microcirculation in patients with acute myocardial infarction (AMI). MATERIAL AND

methodsA total of 120 patients with first acute anterior wall ST segment elevation myocardial infarction who underwent P-PCI were randomly divided into two groups: the NIC group (A,

resultsThe number of patients who achieved TIMI grade 3 (96.67% vs. 86.67%;

conclusionsEarly coronary administration of NIC can significantly reduce the damage in the myocardial microcirculation caused by P-PCI and the myocardial infarct size in patients with AMI.

Indexed as

nicorandilno-reflowprimary percutaneous coronary intervention

Identifiers

PMID29743901
PMCPMC5939542
OpenAlexW2792628225

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.